ALEXA MURPHY: Open Payments
NPI 1609515881 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 56 payments from 17 companies in 2025. Trend: 2023 $1,133 · 2024 $2,422 · 2025 $1,444
Food & beverage: $1,436Consulting: $8
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $340 |
| Regeneron Healthcare Solutions, Inc. | 6 | $139 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| GENZYME CORPORATION | 4 | $111 |
| CSL Behring | 4 | $101 |
| BioCryst US Sales Co., LLC | 4 | $89 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| Genentech USA, Inc. | 3 | $80 |
| Ionis Pharmaceuticals, Inc. | 4 | $72 |
| Incyte Corporation | 3 | $65 |
Products named: TEZSPIRE, DUPIXENT, Hizentra, Xolair, ORLADEYO, DAWNZERA, FASENRA, OPZELURA.
Industry payments across AZ — which companies pay providers there.
